LNTH News & Events

Lantheus Holdings completed the previously announced sale of its single photon emission computed tomography business to SHINE Technologies. Under the terms of the agreement, SHINE has acquired Lantheus' SPECT business, including its diagnostic agents, the portion of the North Billerica, Massachusetts campus that manufactures Lantheus' SPECT products, and the SPECT-related Canadian operations. With the SPECT divestiture finalized, Lantheus will focus on its growing commercial portfolio of PET radiodiagnostics and microbubbles, while also advancing its pipeline of radiopharmaceuticals.

Lifeward (LFWD) announced that its board of directors has appointed Bob Marshall as chairman of the board, effective January 1, 2026. He replaces Joseph Turk, who will transition off the board in connection with his new position at Fresenius Medical Care. Marshall is CFO and treasurer of Lantheus (LNTH).